[Telecobalt at low dose rate. Second report (author's transl)].
D001859:Bone Neoplasms / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D003037:Cobalt Radioisotopes; D005354:Fibrosarcoma / Q000532:radiotherapy; D006801:Humans; D006811:Humerus; D007866:Leg; D008545:Melanoma / Q000532:radiotherapy; D009062:Mouth Neoplasms / Q000532:radiotherapy; D009369:Neoplasms / Q000532:radiotherapy*; D012516:Osteosarcoma / Q000532:radiotherapy; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy; D011867:Radioisotope Teletherapy / Q000379:methods; D011879:Radiotherapy Dosage; D013848:Thigh; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy
D003037:Cobalt Radioisotopes
La téléradiothérapie continue et de faible débit. Deuxième rapport